Loading clinical trials...
Loading clinical trials...
M2951 is an investigational drug under evaluation for treatment of autoimmune and inflammatory disorders. The purpose of the study was to assess the Safety and Efficacy of M2951 in participants with S...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
EMD Serono Research & Development Institute, Inc.
Collaborators
NCT07526350 · Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathies, and more
NCT06875960 · Systemic Lupus Erythematosus (SLE), Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)
NCT06335979 · Systemic Lupus Erythematosus, SLE
NCT06647069 · Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA)
NCT07371468 · Systemic Lupus Erythematosus
Pinnacle Research Group LLC
Anniston, Alabama
Arizona Arthritis & Rheumatology Associates, P.C.
Mesa, Arizona
Arizona Arthritis & Rheumatology Associates, P.C.
Phoenix, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions